Big health industry refers to a compound industry based on biotechnology, information technology and modern medicine, covering biomedical engineering, traditional Chinese medicine, medical and health services and many other fields. The following small series brings leading stocks of health products, which companies are of great benefit to you. Let's have a look.

What are the leading stocks of health products?

The leading stocks of the concept of health care products are:

Tomson Bianjian 300 146: the leader of health products. The P/E ratio of Tomson Bianjian is 26. 15. In 2020, the revenue increased by 15.83% to 6.095 billion, and the gross profit margin reached 62.82%.

The leader of nutrition and health care products in China, and also the leader of pharmacies and online dual channels in the dietary supplement industry; Products include protein powder, vitamins, liquid calcium and so on. The brands are "Tomson Bianjian" and Jianliduo.

In the past seven days, Tomson Bianjian's share price rose by 3.95%, and fell by -4.25% in 2022, with the highest price of 26.73 yuan and a market value of 45.228 billion yuan.

Dong 'e Ejiao 000423: The company's tenth five-year new product development plan: drug direction (Ejiao classic prescription, Ejiao blood-enriching, Ejiao lung-moistening, etc. ), health care products and functional foods (Ejiao nourishing the heart and calming the nerves, beautifying and anti-aging, regulating menstruation and preparing for pregnancy, improving immunity, etc. At present, there is no plan to launch new products such as Ejiao drinks.

Livzon Group 0005 13: Potential leader of respiratory and inhalation preparations. Its main products include Shenqi Fuzheng injection, Livzon Dele (dipotassium citrate) series products, antiviral particle HIV antibody diagnostic reagents and so on. The company's western medicine pharmacy, raw material medicine and health care products business grew steadily.

Tetracyclic organism 005 18: R&D, production and sales of drugs and health products.

What are the leading stocks in the big health industry?

1, Dean Diagnostics (28.30+ 1.25%, consulting unit): The high-end accurate diagnosis technology platform has been laid out, and the cooperative construction business has grown rapidly, and it has expanded to a number of 3A hospital customers to build an accurate platform.

2. Kangmei Bio (23.45+0.04%, clinical unit): obtained the product registration certificate of 145 in vitro diagnostic reagent, covering biochemistry, blood cells and other fields.

3. Jiuzhoutong (20.04+0.50%): Haoyaoshi Pharmacy, a wholly-owned subsidiary of Jiuzhoutong, signed a strategic cooperation framework agreement with Kang Sheng Medicine, and plans to gradually realize the cooperation between Kangyuan medicine series and big health food series within three years.

4. Lejin Health (6.26-1.1%,consulting unit): The company is one of the earliest enterprises engaged in the research and development of home sauna equipment in China, and is a pioneer in promoting healthy sauna to ordinary families in China. The main products mainly include domestic far-infrared sauna rooms and portable sauna products.

5. Peking University Medicine (000788): Acquired Beijing Medical Medicine to complete business expansion. 20 1 1, the company acquired 0/00% equity of Buyi Medicine from Peking University International Hospital Group. From 20 1 1, Beijing Pharmaceutical and its subsidiaries are included in the company's statements. The company added the sales and circulation business of drugs and medical devices, and the pharmaceutical industry chain was further extended.

Top ten leading stocks of traditional Chinese medicine

The top ten leading Chinese medicine stocks are Pien Tze Huang, Yunnan Baiyao, Jiuzhitang, essence pharmaceutical, Tongrentang, Baiyun Mountain, Kangyuan Pharmaceutical, Jiang Zhong Pharmaceutical, Guangyuyuan and Ma Yinglong.

In 20 19, the market scale of medical and health service industry in China reached 4.6 trillion yuan, with 2015-2019 cagr12%, and it is expected to reach 10 trillion yuan in 2030.

Among them, China's traditional Chinese medicine health industry has also grown with the development of medical and health services. In 20 19, the health market scale of Chinese medicine university was 91700 million yuan. According to the in-depth analysis of the traditional Chinese medicine industry and the Research Report on the Guidance of the 13th Five-Year Development Plan, the scale of the traditional Chinese medicine industry is expected to reach 2,242 billion yuan in 2030, and it is expected to be 20 19-2030 CAGR 1 1.3%.

What are the leading stocks in Healthy China?

1, Hejia shares (12.34+0.33%, clinical shares)

In the field of medical services, PPP model has been tried for many years. Recently, it was announced to cooperate with the Third People's Hospital of Weishi County, Henan Province and the Health Planning Bureau of Pingtang County, Guizhou Province to carry out medical construction services.

The total investment of Hejia Co., Ltd. and Pingtang County, Guizhou Province is as high as 2.9 billion yuan, which provides a guarantee for the future development of the company. Hejia Co., Ltd. is a pioneer in the transformation of medical device enterprises into medical service industry, especially in the fields of hemodialysis, rehabilitation, medical information and so on.

2. Baiyi Pharmaceutical (15.40+0. 13%, Clinical Unit)

As a leading enterprise of anti-tumor drugs, it has actively transformed into the cancer medical service industry in recent years. 2065438+In April 2006, Anhui Cancer Expert Group, a subsidiary of the company, was formally established.

It has acquired 1 third-class hospital, signed 1 1 cancer treatment center with no equity relationship and 8 cancer treatment centers with equity cooperation, and will develop according to the model of big doctor enterprise group in the future. Medical service is expected to become an important performance growth point of the company in the future.

3. Yuyue Medical (22.93+2.92%, diagnostic unit)

It is the largest professional manufacturer of rehabilitation nursing, medical oxygen supply and medical clinical series medical devices in China, and a leading enterprise in the domestic medical device industry. It produces more than 50 kinds of products, which is one of the richest products in the same industry in China.

Official website shows that at present, the market share of the company's oxygen generator, atomizer, sphygmomanometer, stethoscope and ultra-light oxygen valve has reached the first place in China, and the products of oxygen generator have reached the first place in global sales.

The market share of wheelchair and electronic sphygmomanometer is the second in China. In addition, the company also actively entered the Internet medical care to create a cloud health platform for chronic disease management. The company's perfect product and industrial layout are expected to fully benefit from the outbreak of the old-age medical market.

What are the leading stocks in general big health stocks?

1. Xinyue Health (002 162), Shanghai Xinyue Health Group Co., Ltd. is engaged in large-scale health industry, building ceramics business and ecological health building materials business. The company's total operating income in 2020 was165438+95 million, a year-on-year increase of 2.44%; The gross profit is 3. The net profit is 38 1 100 million yuan, and the net profit is 3510.7 million yuan.

2. Baiyun Mountain (6000332)( 1) Research, development, manufacture and sales of Chinese and western medicines, chemical raw materials, natural medicines, biomedicine and intermediates of chemical raw materials; (two) the wholesale, retail and import and export business of western medicine, Chinese medicine and medical devices; (3) production and sales of R&D health products; And (4) investment in health industries such as medical services, health management, health care and old-age care. In 2020, the company's total operating income was 665,438+0.67 billion, a year-on-year increase of-5.05%; Gross profit was 65.438+0.044 billion yuan and net profit was 2.628 billion yuan;

3. Winbond Health (002004). On February 20th, Winbond Health said in response to an investor's question that at present, the company has determined a big health development strategy, focusing on medicine and medical main business. The company will introduce strategic investors according to the overall development strategic planning and various factors. In 2020, the company's total operating income was 65.438+0.088 billion, a year-on-year increase of 7.78%; Gross profit is 44%. The net profit is 5.5 billion yuan and 69 million yuan.

4. Guo Xin Health (000503), both parties will jointly promote the innovative development of Hefu smart medical care and big health industry, focusing on building a health and safety service system. The company's total operating income in 2020 II. An increase of 5.9 billion yuan or 62%; Gross profit is 30.45 million yuan and net profit is-242 million yuan.

Verb (abbreviation of verb) Jiangsu Wuzhong (600200), Jiangsu Wuzhong announced that the company has established the development direction with medical and health industry as its core industry under the circumstances of changes in macroeconomic environment and industrial development situation. On the one hand, we insist on deepening the main business of pharmaceutical manufacturing, on the other hand, we choose opportunities to extend in other health sub-fields; In order to accurately reflect the company's business structure and strategic development direction, and make the company's name and business scope match the company's strategic planning and business, the company plans to change its name and business scope, and modify the corresponding clauses in the company's articles of association.